Loop Diuretic Down-Titration at Discharge in Patients Hospitalized for Acute Heart Failure
Authors:
Open Access
- 7 March 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in ESC Heart Failure
- Vol. 11 (3) , 1739-1747
Abstract
Aims: The current literature provides limited guidance on the best diuretic strategy post-hospitalization for acute heart failure (AHF). It is postulated that the efficacy and safety of the outpatient diuretic regimen may be significantly influenced by the degree of fluid overload (FO) encountered during hospitalization. We hypothesize that in patients with more pronounced FO, reducing their regular oral diuretic dosage might be associated with an elevated risk of unfavourable clinical outcomes. Methods and results: It was a retrospective observational study of 410 patients hospitalized for AHF in which the dose of furosemide at admission and discharge was collected. Patients were categorized across diuretic dose status into two groups: (i) the down-titration group and (ii) the stable/up-titration group. FO status was evaluated by a clinical congestion score and circulating biomarkers. The endpoint of interest was the composite of time to all-cause death and/or heart failure readmission. A multivariable Cox proportional hazard regression model was constructed to analyse the endpoints. The median age was 86 (78–92) years, 256 (62%) were women, and 80% had heart failure with preserved ejection fraction. After multivariate adjustment, the down-titration furosemide equivalent dose remained not associated with the risk of the combined endpoint in the whole sample (hazard ratio 1.34, 95% confidence interval 0.86–2.06, P = 0.184). The risk of the combination of death and/or worsening heart failure associated with the diuretic strategy at discharge was significantly influenced by FO status, including clinical congestion scores and circulating proxies of FO like BNP and cancer antigen 125. Conclusions: In patients hospitalized for AHF, furosemide down-titration does not imply an increased risk of mortality and/or heart failure readmission. However, FO status modifies the effect of down-titration on the outcome. In patients with severe congestion or residual congestion at discharge, down-titration was associated with an increased risk of mortality and/or heart failure readmission.Keywords
This publication has 28 references indexed in Scilit:
- Worsening of Chronic Heart Failure: Definition, Epidemiology, Management and Prevention. A Clinical Consensus Statement by the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2023
- Association Between Changes in Loop Diuretic Dose and Outcomes in Acute Heart FailureESC Heart Failure, 2023
- Effect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart FailureJAMA, 2023
- Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2020
- Reduced Loop Diuretic Use in Patients Taking Sacubitril/Valsartan Compared with Enalapril: The PARADIGM-HF TrialEuropean Journal of Heart Failure, 2019
- The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of CardiologyEuropean Journal of Heart Failure, 2019
- Loop Diuretics, Renal Function and Clinical Outcome in Patients with Heart Failure and Reduced Ejection FractionEuropean Journal of Heart Failure, 2015
- Loop Diuretic Dose Adjustments after a Hospitalization for Heart Failure: Insights From ASCEND-HFEuropean Journal of Heart Failure, 2015
- BNP-Guided vs Symptom-Guided Heart Failure TherapyJAMA, 2009
- Relation of Loop Diuretic Dose to Mortality in Advanced Heart FailureThe American Journal of Cardiology, 2006